NO961589L - Pharmaceutical mixtures - Google Patents
Pharmaceutical mixturesInfo
- Publication number
- NO961589L NO961589L NO961589A NO961589A NO961589L NO 961589 L NO961589 L NO 961589L NO 961589 A NO961589 A NO 961589A NO 961589 A NO961589 A NO 961589A NO 961589 L NO961589 L NO 961589L
- Authority
- NO
- Norway
- Prior art keywords
- itch
- salts
- ibuprofen
- flurbiprofen
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Bruk av ibuprofen, flurbiprofen og/eller et eller flere av deres farmasøytisk akseptable salt eller salter til bruk ved lokal behandling (inkluderende kosmetisk behandling) av pruritus (kløe) hos dyr, inkludert mennesker, beskrives. Det beskrives også farmasøytiske blandinger med kløestillende effekt som omfatter ibuprofen, flurbiprofen og/eller et eller flere av deres farmasøytisk akseptable salt eller salter som det eller de kløestillende midler. Blandingene kan også om- fatte en farmasøytisk akseptabel fortynnende forbindelse eller bærer, en fortykkende forbindelse, et pH-regulerende middel, et konserveringsmiddel og et fuktighetsmiddel. Bruk av ibupro- fen, flurbiprofen og/eller deres salt eller salter under fremstilling av et medikament til behandling av kløe og bruk av de ovennevnet blandinger i behandling av kløe hos dyr, inkludert mennesker, blir også krevet. Dersom kløen som behandles ifølge oppfinnelsen har blitt fremkalt med bestrål- ing med UV-B stråling, er det kløestillende middel fortrinns- vis et annet enn ibuprofen alene.The use of ibuprofen, flurbiprofen, and / or one or more of their pharmaceutically acceptable salts or salts for use in local treatment (including cosmetic treatment) of pruritus (itching) in animals, including humans. Also disclosed are pharmaceutical compositions having an anti-itch effect which include ibuprofen, flurbiprofen and / or one or more of their pharmaceutically acceptable salts or salts as the anti-itch agent (s). The compositions may also comprise a pharmaceutically acceptable diluent or carrier, a thickening compound, a pH regulating agent, a preservative and a humectant. The use of ibuprofen, flurbiprofen and / or their salt or salts in the preparation of an itch to treat itching and the use of the above-mentioned compositions in the treatment of itching in animals, including humans, are also required. If the itch that is treated according to the invention has been induced by irradiation with UV-B radiation, the itch agent is preferably different from ibuprofen alone.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939321671A GB9321671D0 (en) | 1993-10-20 | 1993-10-20 | Pharmaceutical composition |
| GB9405024A GB9405024D0 (en) | 1994-03-15 | 1994-03-15 | Pharmaceutical composition |
| GB9405025A GB9405025D0 (en) | 1994-03-15 | 1994-03-15 | Pharmaceutical composition |
| PCT/EP1994/003442 WO1995011017A1 (en) | 1993-10-20 | 1994-10-19 | Ibuprofen and flurbiprofen as anti-pruritic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO961589D0 NO961589D0 (en) | 1996-04-19 |
| NO961589L true NO961589L (en) | 1996-06-17 |
Family
ID=27266892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961589A NO961589L (en) | 1993-10-20 | 1996-04-19 | Pharmaceutical mixtures |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0724438A1 (en) |
| JP (1) | JPH09504018A (en) |
| AU (1) | AU690155B2 (en) |
| CA (1) | CA2174619A1 (en) |
| CZ (1) | CZ112496A3 (en) |
| FI (1) | FI961716A (en) |
| HU (1) | HUT74448A (en) |
| NO (1) | NO961589L (en) |
| PL (1) | PL314036A1 (en) |
| SK (1) | SK48896A3 (en) |
| WO (1) | WO1995011017A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9606429D0 (en) * | 1996-03-27 | 1996-06-05 | Boots Co Plc | Pharmaceutical compositions |
| ATE291429T1 (en) * | 1996-11-25 | 2005-04-15 | Toray Industries | REMEDIES FOR ITCHING |
| AU2006228869A1 (en) | 2005-03-30 | 2006-10-05 | Astion Pharma A/S | Oxaprozin or a closely related compound for the treatment of eczema |
| CN101932316A (en) * | 2007-12-21 | 2010-12-29 | Paz医药发展有限公司 | Pharmaceutical preparation and preparation thereof and its application in the relevant neuropathy of treatment pain |
| MX352187B (en) * | 2009-12-16 | 2017-11-13 | Shasun Pharmaceuticals Ltd Star | Composition of dexibuprofen transdermal hydrogel. |
| EP2468270A1 (en) | 2010-12-21 | 2012-06-27 | GALENpharma GmbH | (R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases |
| GB2493914A (en) * | 2011-08-19 | 2013-02-27 | Univ Jw Goethe Frankfurt Main | Flurbiprofen and related compounds for the treatment of skin diseases |
| CN113262216A (en) * | 2020-02-14 | 2021-08-17 | 北京泰德制药股份有限公司 | External preparation for eliminating skin surface red swelling and easing pain |
| WO2024101489A1 (en) * | 2022-11-11 | 2024-05-16 | 주식회사 지케이랩 | Method for preparing external gel formulation containing propionic acid-based non-steroidal drug as active ingredient for treatment of itching |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2075837B (en) * | 1980-05-14 | 1984-03-14 | Hisamitsu Pharmaceutical Co | Topical pharmaceutical gel containing anti-inflammatory analgesic agents |
| DE3317124A1 (en) * | 1983-05-07 | 1984-11-08 | Teroson Gmbh, 6900 Heidelberg | DEVICE FOR APPLYING LIQUIDS WITH DIFFERENT CONSISTENCY |
| JPS59222409A (en) * | 1983-06-01 | 1984-12-14 | Nippon Redarii Kk | Anti-inflammatory and analgesic gel ointment |
| JPH0735330B2 (en) * | 1986-03-12 | 1995-04-19 | 久光製薬株式会社 | Cream composition for external use |
| JPH01224328A (en) * | 1988-03-01 | 1989-09-07 | Kao Corp | Antipruritic agent composition |
| US5093133A (en) * | 1990-01-24 | 1992-03-03 | Mcneil-Ppc, Inc. | Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
-
1994
- 1994-10-19 PL PL94314036A patent/PL314036A1/en unknown
- 1994-10-19 HU HU9601031A patent/HUT74448A/en unknown
- 1994-10-19 AU AU80586/94A patent/AU690155B2/en not_active Ceased
- 1994-10-19 SK SK488-96A patent/SK48896A3/en unknown
- 1994-10-19 WO PCT/EP1994/003442 patent/WO1995011017A1/en not_active Application Discontinuation
- 1994-10-19 EP EP94931531A patent/EP0724438A1/en not_active Withdrawn
- 1994-10-19 CZ CZ961124A patent/CZ112496A3/en unknown
- 1994-10-19 CA CA002174619A patent/CA2174619A1/en not_active Abandoned
- 1994-10-19 JP JP7511332A patent/JPH09504018A/en active Pending
-
1996
- 1996-04-19 FI FI961716A patent/FI961716A/en unknown
- 1996-04-19 NO NO961589A patent/NO961589L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT74448A (en) | 1996-12-30 |
| HU9601031D0 (en) | 1996-06-28 |
| PL314036A1 (en) | 1996-08-05 |
| JPH09504018A (en) | 1997-04-22 |
| AU690155B2 (en) | 1998-04-23 |
| FI961716A0 (en) | 1996-04-19 |
| SK48896A3 (en) | 1997-03-05 |
| CZ112496A3 (en) | 1997-04-16 |
| WO1995011017A1 (en) | 1995-04-27 |
| CA2174619A1 (en) | 1995-04-27 |
| NO961589D0 (en) | 1996-04-19 |
| EP0724438A1 (en) | 1996-08-07 |
| FI961716A (en) | 1996-06-03 |
| AU8058694A (en) | 1995-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20050204L (en) | Combinations of drugs for the treatment of neoplasms | |
| CA2120303A1 (en) | Cyclic adhesion inhibitors | |
| BRPI0006634B8 (en) | topical composition comprising feverfew extract in the treatment and prevention of inflammatory disorders | |
| NO20012896L (en) | Method of treating cerebral ischemia and use of erythropoietin or erythropoietin derivatives pretreatment of cerebral ischemia | |
| ATE489082T1 (en) | PHARMACEUTICAL COMPOSITIONS FOR TREATING SKIN CONDITIONS | |
| CA2305721A1 (en) | Phototherapy methods and systems | |
| ATE234089T1 (en) | PREPARATIONS CONTAINING SCLAREOL AND SCLAREOLIDES FOR THE TREATMENT OF MICROBIAL INFECTIONS | |
| NO20050450L (en) | Combination of ZD6474, an inhibitor of vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer | |
| RU94020410A (en) | Method of vomiting treatment or prophylaxis in mammalian and human using the certain quinuclidine, piperidine, azanorbornane, ethylenediamine derivatives and related compounds | |
| NO961589L (en) | Pharmaceutical mixtures | |
| RU94015599A (en) | Use of n-acetyl-l-cysteine and its derivatives for skin wrinkle formation regulation and/or skin atrophy, composition prepared on the basis of n-acetyl-l-cysteine and its derivatives | |
| CZ225995A3 (en) | The use of riluzol for preparing medicament intended for treating neuronal degeneration caused by aids | |
| CA2388939A1 (en) | Therapeutic treatments for blood cell deficiencies | |
| NO934706L (en) | Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines | |
| ES2136252T3 (en) | TREATMENT OF DISEASES CAUSED BY SEBACEA GLAND DISORDERS THROUGH THE USE OF ACIL COA CHOLESTEROL ACIL TRANSFERASE INHIBITORS. | |
| BR0316458A (en) | Compound, pharmaceutical composition, method of treating or preventing disease, method for enhancing cognition in a healthy patient, and use of a compound | |
| ATE336997T1 (en) | FULVIC ACID AND ITS USE IN THE TREATMENT OF VARIOUS MEDICAL CONDITIONS | |
| ES2017808A6 (en) | Growth inhibiting agent and the use thereof. | |
| RU94031161A (en) | PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING, METHOD FOR TREATING DISORDERS DEVELOPING DUE TO NEURODEGENERATIVE PROCESSES | |
| BRPI0411364A (en) | compounds having phosphatidylinositol 3-kinase inhibitory activity and methods of use thereof | |
| CA2178760A1 (en) | HIV Protease Inhibitors | |
| DK0520200T3 (en) | Imadazole compounds, their preparation and use | |
| NZ324380A (en) | Therapeutic benzimidazole compounds and their use in treatment of virus infections | |
| PT1140113E (en) | USE OF BISPHOSPHANTS FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS PROCESSES | |
| DE69232417D1 (en) | MICHELLAMINE FOR USE AS AN ANTIVIRAL ACTIVE SUBSTANCE, COMPOSITION AND TREATMENT METHOD |